rethinkPeptides Search
Menu
Study breakdown

Different Diabetes Drugs Affect Glucagon and GLP-1 Levels Differently Over Time

evidence
The takeaway

Glucose-lowering medications show differential longitudinal effects on glucagon and GLP-1 levels, with implications for understanding drug mechanisms and optimizing combination therapy.

Hormonal fingerprints

Each diabetes drug class creates a distinct pattern of glucagon/GLP-1 changes — understanding these patterns enables more precise drug selection

What the researchers found

Glucose-lowering medications show distinct longitudinal effects on glucagon and GLP-1 levels, informing drug mechanism understanding and combination optimization.

Why it matters

Understanding how each diabetes drug affects gut hormones helps predict effectiveness and design better combination therapies.

How the study worked

Longitudinal analysis of glucagon and GLP-1 levels during treatment with various glucose-lowering medications.

What this study cannot tell us

Details in full paper.

How to read the evidence

Longitudinal hormonal analysis.

When this study was published

Published in 2025.

The bigger picture

Hormonal profiling of diabetes drugs enables precision selection based on individual patients' hormonal patterns.

Questions still open

  • Which drug combination provides optimal glucagon suppression + GLP-1 enhancement?
  • Do hormonal effects predict clinical response?
  • Should hormonal monitoring guide drug selection?

Common questions

Do diabetes drugs affect hormones differently?
Yes. Different drugs create distinct patterns of glucagon and GLP-1 changes over time. Drugs that lower glucagon AND raise GLP-1 may provide the best blood sugar control.
Does this affect which drug I should take?
Understanding how each drug affects your hormones could help your doctor choose the most effective medication or combination for your specific situation.

Read the original research

Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).

Diabetes care, 49(2), 325-334

Citation

Kahn, Steven E; Tripputi, Mark; Lachin, John M; Balasubramanyam, Ashok; Banerji, Mary Ann; Barzilay, Joshua; Cohen, Robert M; Garvey, W Timothy; Gramzinski, Michaela R; Rasouli, Neda; Rhee, Mary; Seegmiller, Jesse C; Singh, Vatsala; Sivitz, William I; Steffes, Michael W; Utzschneider, Kristina; DeFronzo, Ralph A. (2026). Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).. Diabetes care, 49(2), 325-334. https://doi.org/10.2337/dc25-2186